Clinical Trial Update: Study for the Treatment of Transfusional Iron Overload in Myelodysplastic Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for treating transfusional iron overload in patients with myelodysplastic syndromes; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload
• Myelodysplastic Syndromes

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Myelodysplastic Syndromes, Iron Overload | Phase 4 | Status: COMPLETED | Results posted: 2021-06-24